132 related articles for article (PubMed ID: 12840669)
21. Genetics of inflammatory bowel disease: progress and prospects.
Mathew CG; Lewis CM
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
[TBL] [Abstract][Full Text] [Related]
22. [Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?].
Dobrowolska-Zachwieja A; Kaczmarek M; Hoppe-Gołebiewska J; Kalak R; Słomski R; Linke K
Pol Merkur Lekarski; 2005 May; 18(107):560-5. PubMed ID: 16161956
[TBL] [Abstract][Full Text] [Related]
23. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease.
Weiss B; Shamir R; Bujanover Y; Waterman M; Hartman C; Fradkin A; Berkowitz D; Weintraub I; Eliakim R; Karban A
J Pediatr; 2004 Aug; 145(2):208-12. PubMed ID: 15289769
[TBL] [Abstract][Full Text] [Related]
24. Is it time to re-classify Crohn's disease?
Fedorak RN
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():99-106. PubMed ID: 15588801
[TBL] [Abstract][Full Text] [Related]
25. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
Agius LM
J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
[TBL] [Abstract][Full Text] [Related]
26. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
28. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
29. Genome scan analyses and positional cloning strategy in IBD: successes and limitations.
Wild GE; Rioux JD
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):541-53. PubMed ID: 15157826
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease in children: a pediatrician's perspective.
Cuffari C
Minerva Pediatr; 2006 Apr; 58(2):139-57. PubMed ID: 16835574
[TBL] [Abstract][Full Text] [Related]
31. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population.
Núñez C; Barreiro M; Domínguez-Muñoz JE; Lorenzo A; Zapata C; Peña AS
Am J Gastroenterol; 2004 Mar; 99(3):450-6. PubMed ID: 15056084
[TBL] [Abstract][Full Text] [Related]
32. CARD15/NOD2 mutations in Crohn's disease.
Hugot JP
Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
[TBL] [Abstract][Full Text] [Related]
33. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients.
Giachino D; van Duist MM; Regazzoni S; Gregori D; Bardessono M; Salacone P; Scaglione N; Sostegni R; Sapone N; Bresso F; Sambataro A; Gaia E; Pera A; Astegiano M; De Marchi M
Eur J Hum Genet; 2004 Mar; 12(3):206-12. PubMed ID: 14747834
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.
Newman B; Siminovitch K
Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304
[TBL] [Abstract][Full Text] [Related]
36. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
[TBL] [Abstract][Full Text] [Related]
37. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population.
O'Callaghan NJ; Adams KE; van Heel DA; Cavanaugh JA
Scand J Gastroenterol; 2003 May; 38(5):533-4. PubMed ID: 12795465
[TBL] [Abstract][Full Text] [Related]
38. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S
Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772
[TBL] [Abstract][Full Text] [Related]
40. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
